David Henry's JCSO Podcast

David Henry's JCSO podcast, November 2014


 

Among the items featured in Dr David Henry’s monthly podcast for The Journal of Community and Supportive Oncology, are reports on congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia and on the impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in head and neck cancer patients on cisplatin chemotherapy. Two articles focus on patient quality of life: one examines peripheral neuropathy and its impact on QoL after chemotherapy and another looks at QoL and symptoms after stereotactic body radiotherapy in early-stage lung cancer. There’s also a Case Report about a patient with superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma, a feature article on choice of anesthesia during cancer surgery and patient outcomes, and a comprehensive and informative round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements.

Recommended Reading

PET-CT better predicted follicular lymphoma survival
MDedge Hematology and Oncology
A wonderful life
MDedge Hematology and Oncology
Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma
MDedge Hematology and Oncology
Aspartame, sweetened drinks don’t increase risk of NHL
MDedge Hematology and Oncology
CHMP recommends ibrutinib for CLL, MCL
MDedge Hematology and Oncology
Maintenance may be unnecessary in FL
MDedge Hematology and Oncology
Idelalisib approved to treat CLL, FL in EU
MDedge Hematology and Oncology
FDA approves idelalisib for CLL, SLL and FL
MDedge Hematology and Oncology
Study supports new gold standard for FL
MDedge Hematology and Oncology
CHMP recommends idelalisib for CLL, FL
MDedge Hematology and Oncology